<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1020-3397</journal-id>
<journal-title><![CDATA[Eastern Mediterranean Health Journal]]></journal-title>
<abbrev-journal-title><![CDATA[East. Mediterr. health j.]]></abbrev-journal-title>
<issn>1020-3397</issn>
<publisher>
<publisher-name><![CDATA[Alexandria: WHO, Regional Office for the Eastern Mediterranean]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1020-33972007000400004</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Exudative pleural effusion: effectiveness of pleural fluid analysis and pleural biopsy]]></article-title>
<article-title xml:lang="fr"><![CDATA[Pleurésie exsudative: efficacité de l'analyse du liquide pleural et de la biopsie pleurale]]></article-title>
<article-title xml:lang="ar"><![CDATA[&#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1600;&#1576;&#1610; &#1575;&#1604;&#1606;&#1590;&#1581;&#1610;]]></article-title>
<article-title xml:lang="ar"><![CDATA[&#1601;&#1593;&#1617;&#1614;&#1575;&#1604;&#1610;&#1577; &#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1608;&#1575;&#1604;&#1582;&#1586;&#1593;&#1577; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577;]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Heidari]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bijani]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Eissazadeh]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Heidari]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Babol University of Medical Sciences Shahid Beheshti Hospital Department of Medicine]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Azad University Faculty of Veterinary Medicine ]]></institution>
<addr-line><![CDATA[Karaj ]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2007</year>
</pub-date>
<volume>13</volume>
<numero>4</numero>
<fpage>765</fpage>
<lpage>773</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_arttext&amp;pid=S1020-33972007000400004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_abstract&amp;pid=S1020-33972007000400004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_pdf&amp;pid=S1020-33972007000400004&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="ar"><p><![CDATA[&#1602;&#1575;&#1585;&#1606; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1601;&#1610; &#1607;&#1584;&#1607; &#1575;&#1604;&#1583;&#1585;&#1575;&#1587;&#1577; &#1576;&#1610;&#1606; &#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1548; &#1608;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1582;&#1586;&#1593;&#1577; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577;&#1548; &#1601;&#1610; &#1578;&#1588;&#1582;&#1610;&#1589; 100 &#1581;&#1575;&#1604;&#1577; &#1604;&#1605;&#1585;&#1590;&#1609; &#1605;&#1589;&#1575;&#1576;&#1610;&#1606; &#1576;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1580;&#1606;&#1576;&#1610; &#1606;&#1590;&#1581;&#1610;&#1548; &#1601;&#1610; &#1576;&#1575;&#1576;&#1608;&#1604;&#1548; &#1576;&#1580;&#1605;&#1607;&#1608;&#1585;&#1610;&#1577; &#1573;&#1610;&#1585;&#1575;&#1606; &#1575;&#1604;&#1573;&#1587;&#1604;&#1575;&#1605;&#1610;&#1577;. &#1608;&#1602;&#1583; &#1578;&#1571;&#1603;&#1617;&#1614;&#1583;&#1578; &#1575;&#1604;&#1573;&#1589;&#1575;&#1576;&#1577; &#1576;&#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1587;&#1604;&#1617;&#1610;&#1548; &#1571;&#1608; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579; &#1605;&#1606; &#1582;&#1604;&#1575;&#1604; &#1603;&#1588;&#1601; &#1593;&#1589;&#1610;&#1575;&#1578; &#1589;&#1575;&#1605;&#1583;&#1577; &#1604;&#1604;&#1581;&#1605;&#1590; &#1601;&#1610; &#1587;&#1608;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1587;&#1583;&#1548; &#1571;&#1608; &#1582;&#1604;&#1575;&#1610;&#1575; &#1608;&#1585;&#1605;&#1610;&#1577; &#1601;&#1610; &#1593;&#1610;&#1606;&#1575;&#1578; &#1606;&#1587;&#1610;&#1580;&#1610;&#1577;. &#1608;&#1578;&#1576;&#1610;&#1617;&#1614;&#1606; &#1571;&#1606; &#1575;&#1604;&#1571;&#1605;&#1585;&#1575;&#1590; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;&#1577; &#1603;&#1575;&#1606;&#1578; &#1587;&#1576;&#1576; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1606;&#1590;&#1581;&#1610; &#1601;&#1610; 43% &#1605;&#1606; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609;&#1548; &#1601;&#1610; &#1581;&#1610;&#1606; &#1603;&#1575;&#1606; &#1575;&#1604;&#1587;&#1604; &#1607;&#1608; &#1587;&#1576;&#1576; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1601;&#1610; 33% &#1605;&#1606; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609;. &#1608;&#1576;&#1604;&#1594;&#1578; &#1606;&#1587;&#1576;&#1577; &#1575;&#1604;&#1581;&#1587;&#1575;&#1587;&#1610;&#1577; &#1575;&#1604;&#1578;&#1588;&#1582;&#1610;&#1589;&#1610;&#1577; &#1604;&#1604;&#1582;&#1586;&#1593;&#1577; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577; &#1604;&#1583;&#1609; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609; &#1576;&#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1587;&#1604;&#1617;&#1610; 70% &#1608;&#1604;&#1583;&#1609; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609; &#1576;&#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579; 54%&#1548; &#1603;&#1605;&#1575; &#1576;&#1604;&#1594;&#1578; &#1606;&#1587;&#1576;&#1577; &#1575;&#1604;&#1581;&#1587;&#1575;&#1587;&#1610;&#1577; &#1575;&#1604;&#1578;&#1588;&#1582;&#1610;&#1589;&#1610;&#1577; &#1604;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1604;&#1583;&#1609; &#1605;&#1585;&#1590;&#1609; &#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1587;&#1604;&#1617;&#1610; 33% &#1608;&#1604;&#1583;&#1609; &#1605;&#1585;&#1590;&#1609; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579; 70%. &#1608;&#1580;&#1575;&#1569;&#1578; &#1606;&#1578;&#1575;&#1574;&#1580; &#1575;&#1604;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1605;&#1588;&#1578;&#1600;&#1585;&#1603; &#1604;&#1604;&#1582;&#1586;&#1593;&#1577; &#1608;&#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1573;&#1610;&#1580;&#1575;&#1576;&#1610;&#1577; &#1601;&#1610; 99% &#1605;&#1606; &#1581;&#1575;&#1604;&#1575;&#1578; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1587;&#1604;&#1617;&#1610;&#1548; &#1608;91% &#1605;&#1606; &#1581;&#1575;&#1604;&#1575;&#1578; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The study compared pleural fluid analysis and pleural biopsy in the diagnosis of 100 patients with exudative pleural effusion (PE) in Babol, Islamic Republic of Iran. Tuberculous pleurisy and malignant pleural effusion were confirmed by the identification of acid-fast bacilli from body fluids or tumour cells from tissue specimens. Malignant diseases and tuberculosis were the causes of exudative PE in 43% and 33% of patients respectively. The diagnostic sensitivity of pleural biopsy in patients with tuberculous PE and malignant PE was 70% and 54%, and the diagnostic sensitivity of pleural fluid analysis was 33% and 70% respectively. Combined pleural biopsy and pleural fluid analysis were positive in 97% of tuberculous PE cases and 91% of malignant PE.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[L’étude a comparé l’analyse du liquide pleural et la biopsie de la plèvre dans le diagnostic de 100 patients présentant une pleurésie exsudative (PE) et résidant à Babol (République islamique d’Iran). La pleurésie tuberculeuse et la pleurésie exsudative maligne ont chacune été confirmées par identification de bacilles acidorésistants isolés dans le liquide pleural ou les cellules tumorales issues d’échantillons tissulaires. Malignité et tuberculose se sont avérées être respectivement à l’origine de 43 % et 33 % des cas. En ce qui concerne la sensibilité diagnostique de ces deux tests, la biopsie pleurale atteignait respectivement 70 % et 54 % dans la PE tuberculeuse et la PE maligne contre respectivement 33 % et 70 % pour l’analyse du liquide pleural. La combinaison biopsie pleurale/analyse du liquide pleural a obtenu des résultats positifs dans 97 % des cas de PE tuberculeuse et 91 % des cas de PE maligne.]]></p></abstract>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESEARCH    ARTICLES</b></font></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="4">Exudative pleural    effusion: effectiveness of pleural fluid analysis and pleural biopsy </font></b></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Pleurésie exsudative    : efficacité de l'analyse du liquide pleural et de la biopsie pleurale </b></font></p>     <p>&nbsp;</p>     <p align="right"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="3">&#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1600;&#1576;&#1610; &#1575;&#1604;&#1606;&#1590;&#1581;&#1610;:    &#1601;&#1593;&#1617;&#1614;&#1575;&#1604;&#1610;&#1577; &#1578;&#1581;&#1604;&#1610;&#1604;    &#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;    &#1608;&#1575;&#1604;&#1582;&#1586;&#1593;&#1577; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577;</font></b></p>     <p align="right">&nbsp;</p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">B. Heidari<sup>I</sup>;    K. Bijani<sup>I</sup>; M. Eissazadeh<sup>I</sup>; P. Heidari<sup>II</sup></font></b></p>        ]]></body>
<body><![CDATA[<p align="right" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1576;&#1607;&#1586;&#1575;&#1583;    &#1581;&#1610;&#1583;&#1585;&#1610;&#1548; &#1582;&#1590;&#1585; &#1575;&#1604;&#1604;&#1607;    &#1576;&#1610;&#1586;&#1606;&#1610;&#1548; &#1605;&#1593;&#1589;&#1608;&#1605;&#1577;    &#1593;&#1610;&#1587;&#1609; &#1586;&#1575;&#1583;&#1607;&#1548; &#1576;&#1585;&#1607;&#1575;&#1605;    &#1581;&#1610;&#1583;&#1585;&#1610;</font></p>     <p ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Department    of Medicine, Shahid Beheshti Hospital, Babol University of Medical Sciences,    Babol, Islamic Republic of Iran. (Correspondence to B. Heidari: <a href="mailto:heidaribeh@yahoo.com">heidaribeh@yahoo.com</a>)    <br>   <sup>II</sup>Faculty of Veterinary Medicine, Azad University, Karaj, Islamic    Republic of Iran. </font></p>     <p >&nbsp;</p>     <p >&nbsp;</p>   <hr size="1" noshade>         <p align="right" ><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577;</font></b></p>     <p > <font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1602;&#1575;&#1585;&#1606;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1601;&#1610; &#1607;&#1584;&#1607;    &#1575;&#1604;&#1583;&#1585;&#1575;&#1587;&#1577; &#1576;&#1610;&#1606; &#1578;&#1581;&#1604;&#1610;&#1604;    &#1575;&#1604;&#1587;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1548;    &#1608;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1582;&#1586;&#1593;&#1577;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577;&#1548; &#1601;&#1610; &#1578;&#1588;&#1582;&#1610;&#1589;    100 &#1581;&#1575;&#1604;&#1577; &#1604;&#1605;&#1585;&#1590;&#1609; &#1605;&#1589;&#1575;&#1576;&#1610;&#1606;    &#1576;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576; &#1580;&#1606;&#1576;&#1610;    &#1606;&#1590;&#1581;&#1610;&#1548; &#1601;&#1610; &#1576;&#1575;&#1576;&#1608;&#1604;&#1548;    &#1576;&#1580;&#1605;&#1607;&#1608;&#1585;&#1610;&#1577; &#1573;&#1610;&#1585;&#1575;&#1606;    &#1575;&#1604;&#1573;&#1587;&#1604;&#1575;&#1605;&#1610;&#1577;. &#1608;&#1602;&#1583;    &#1578;&#1571;&#1603;&#1617;&#1614;&#1583;&#1578; &#1575;&#1604;&#1573;&#1589;&#1575;&#1576;&#1577;    &#1576;&#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;    &#1575;&#1604;&#1587;&#1604;&#1617;&#1610;&#1548; &#1571;&#1608; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;    &#1605;&#1606; &#1582;&#1604;&#1575;&#1604; &#1603;&#1588;&#1601; &#1593;&#1589;&#1610;&#1575;&#1578;    &#1589;&#1575;&#1605;&#1583;&#1577; &#1604;&#1604;&#1581;&#1605;&#1590; &#1601;&#1610;    &#1587;&#1608;&#1575;&#1574;&#1604; &#1575;&#1604;&#1580;&#1587;&#1583;&#1548;    &#1571;&#1608; &#1582;&#1604;&#1575;&#1610;&#1575; &#1608;&#1585;&#1605;&#1610;&#1577;    &#1601;&#1610; &#1593;&#1610;&#1606;&#1575;&#1578; &#1606;&#1587;&#1610;&#1580;&#1610;&#1577;.    &#1608;&#1578;&#1576;&#1610;&#1617;&#1614;&#1606; &#1571;&#1606; &#1575;&#1604;&#1571;&#1605;&#1585;&#1575;&#1590;    &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;&#1577; &#1603;&#1575;&#1606;&#1578;    &#1587;&#1576;&#1576; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1606;&#1590;&#1581;&#1610;    &#1601;&#1610; 43% &#1605;&#1606; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609;&#1548;    &#1601;&#1610; &#1581;&#1610;&#1606; &#1603;&#1575;&#1606; &#1575;&#1604;&#1587;&#1604;    &#1607;&#1608; &#1587;&#1576;&#1576; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1601;&#1610; 33% &#1605;&#1606;    &#1575;&#1604;&#1605;&#1585;&#1590;&#1609;. &#1608;&#1576;&#1604;&#1594;&#1578;    &#1606;&#1587;&#1576;&#1577; &#1575;&#1604;&#1581;&#1587;&#1575;&#1587;&#1610;&#1577;    &#1575;&#1604;&#1578;&#1588;&#1582;&#1610;&#1589;&#1610;&#1577; &#1604;&#1604;&#1582;&#1586;&#1593;&#1577;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;&#1577; &#1604;&#1583;&#1609; &#1575;&#1604;&#1605;&#1585;&#1590;&#1609;    &#1576;&#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;    &#1575;&#1604;&#1587;&#1604;&#1617;&#1610; 70% &#1608;&#1604;&#1583;&#1609;    &#1575;&#1604;&#1605;&#1585;&#1590;&#1609; &#1576;&#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;    54%&#1548; &#1603;&#1605;&#1575; &#1576;&#1604;&#1594;&#1578; &#1606;&#1587;&#1576;&#1577;    &#1575;&#1604;&#1581;&#1587;&#1575;&#1587;&#1610;&#1577; &#1575;&#1604;&#1578;&#1588;&#1582;&#1610;&#1589;&#1610;&#1577;    &#1604;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1587;&#1575;&#1574;&#1604;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1604;&#1583;&#1609; &#1605;&#1585;&#1590;&#1609;    &#1575;&#1604;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1580;&#1606;&#1576;&#1610;    &#1575;&#1604;&#1587;&#1604;&#1617;&#1610; 33% &#1608;&#1604;&#1583;&#1609;    &#1605;&#1585;&#1590;&#1609; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;    70%. &#1608;&#1580;&#1575;&#1569;&#1578; &#1606;&#1578;&#1575;&#1574;&#1580;    &#1575;&#1604;&#1578;&#1581;&#1604;&#1610;&#1604; &#1575;&#1604;&#1605;&#1588;&#1578;&#1600;&#1585;&#1603;    &#1604;&#1604;&#1582;&#1586;&#1593;&#1577; &#1608;&#1575;&#1604;&#1587;&#1575;&#1574;&#1604;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1573;&#1610;&#1580;&#1575;&#1576;&#1610;&#1577;    &#1601;&#1610; 99% &#1605;&#1606; &#1581;&#1575;&#1604;&#1575;&#1578; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1587;&#1604;&#1617;&#1610;&#1548;    &#1608;91% &#1605;&#1606; &#1581;&#1575;&#1604;&#1575;&#1578; &#1575;&#1604;&#1575;&#1606;&#1589;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1580;&#1606;&#1576;&#1610; &#1575;&#1604;&#1582;&#1576;&#1610;&#1579;.    </font> </p> <hr size="1" noshade>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">ABSTRACT</font></b></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> The study compared    pleural fluid analysis and pleural biopsy in the diagnosis of 100 patients with    exudative pleural effusion (PE) in Babol, Islamic Republic of Iran. Tuberculous    pleurisy and malignant pleural effusion were confirmed by the identification    of acid-fast bacilli from body fluids or tumour cells from tissue specimens.    Malignant diseases and tuberculosis were the causes of exudative PE in 43% and    33% of patients respectively. The diagnostic sensitivity of pleural biopsy in    patients with tuberculous PE and malignant PE was 70% and 54%, and the diagnostic    sensitivity of pleural fluid analysis was 33% and 70% respectively. Combined    pleural biopsy and pleural fluid analysis were positive in 97% of tuberculous    PE cases and 91% of malignant PE. </font></p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RÉSUMÉ</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> L’étude a comparé    l’analyse du liquide pleural et la biopsie de la plèvre dans le diagnostic de    100 patients présentant une pleurésie exsudative (PE) et résidant à Babol (République    islamique d’Iran). La pleurésie tuberculeuse et la pleurésie exsudative maligne    ont chacune été confirmées par identification de bacilles acidorésistants isolés    dans le liquide pleural ou les cellules tumorales issues d’échantillons tissulaires.    Malignité et tuberculose se sont avérées être respectivement à l’origine de    43 % et 33 % des cas. En ce qui concerne la sensibilité diagnostique de ces    deux tests, la biopsie pleurale atteignait respectivement 70 % et 54 % dans    la PE tuberculeuse et la PE maligne contre respectivement 33 % et 70 % pour    l’analyse du liquide pleural. La combinaison biopsie pleurale/analyse du liquide    pleural a obtenu des résultats positifs dans 97 % des cas de PE tuberculeuse    et 91 % des cas de PE maligne.</font> </p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Introduction</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Pleural effusion    (PE) is a common problem in internal medicine practice. In cases with transudate    PE, the diagnosis is usually made without any difficulties but exudative PE    requires careful differential diagnosis that includes tuberculosis (TB) and    metastatic cancers, which are often found to be the cause in a large number    of patients &#91;<i>1-3</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Disease in any    organ can cause exudative PE through a variety of mechanisms including infection,    malignancy, immunologic response, lymphatic abnormality and noninfectious inflammation    &#91;<i>4</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In many areas of    the world, TB is the most common cause of exudative PE &#91;<i>5-7</i>&#93;, but in    regions with a low prevalence rate of TB, and also in patients aged over 60    years, malignant diseases should be considered the most probable cause, although    in older patients a reactivation of previous TB may also present as exudative    PE &#91;<i>8-10</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Despite the development    of new diagnostic methods, closed pleural biopsy and pleural fluid analysis    remain the most common ways of establishing a diagnosis of tuberculous PE or    malignant PE &#91;<i>10-12</i>&#93;. However the value of these procedures is limited    in establishing the cause of PE that results from either malignant or nonmalignant    diseases. Although thoracoscopic biopsy and lavage has increased the diagnostic    rate, the cause for many patients with exudative PE remains unknown or obscure.    In these patients, detection of a treatable cause is very important. Even in    patients with a known malignancy, accurate diagnosis of the cause of PE is essential,    as the treatment and prognosis may vary. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Since TB and malignancy    are among the most frequent causes of PE, in particular exudative PE, in most    parts of the world previous studies have focused on the diagnosis of TB or malignancy    &#91;<i>5,6,9-12</i>&#93;. Although the value of pleural fluid analysis and pleural    biopsy in diagnosis of malignant or tuberculous PE has been shown in several    studies &#91;<i>10-12</i>&#93;, their diagnostic performance for identification of TB    or malignancy in patients with the exudative type of PE has not been studied    or compared yet. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The aim of the    current study was to assess the effectiveness of pleural fluid analysis and    pleural biopsy and the efficacy of combining both procedures in the diagnosis    of TB and malignancy in patients with exudative PE. </font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Methods</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This study was    carried out on 100 consecutive patients with PE admitted to the pulmonary division    of Shaheed Beheshti Hospital in Babol, Islamic Republic of Iran between 1997    and 2001. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Etiological diagnosis    of exudative PE was confirmed according to appropriate clinical and/or laboratory    findings or criteria. All patients were given a clinical examination, chest    radiograph, blood chemistry and thoracentesis. Pleural biopsy with Abrams needle    was performed in all patients except those with an obvious clinical diagnosis    of congestive heart failure or bacterial pneumonia. Pleural fluid analysis was    performed for protein concentration, lactic dehydrogenase (LDH), cultures, as    well as cytologic study for tumour cells. Bacteriological examination of pleural    fluid as well as examination for acid-fast bacilli (AFB) were also performed.    Diagnosis of exudative PE was confirmed according to pleural fluid protein and    LDH level, and the size of the effusion was determined on the basis of chest    radiographs &#91;<i>13</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Other diagnostic    methods such as bronchoscopy and bronchoalveolar lavage were done as clinically    indicated. Bronchoalveolar lavage fluids were examined for AFB by smears and    culture, as well as for tumour cells. In patients with bloody sputum or those    suspected for TB, 3 samples of stained sputum smears as well as 3 sputum samples    for cultures were taken and sent to the TB ward of Babol health centre for examination    of AFB. Standard tuberculin skin test was also performed for all patients. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Definitive diagnosis    of TB was confirmed by identification of AFB from the cultures of the pleural    fluid, bronchoalveolar lavage fluid, or from the pleural biopsy samples by direct    examination. Presence of granulomas with caseous necrosis in biopsy specimens    was confirmative of TB if clinical and radiological findings of TB were also    available. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Diagnosis of malignant    PE was confirmed by identification of tumour cells from the pleural fluid or    pleural tissue samples. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Diagnosis of malignant    mesothelioma was confirmed on the basis of histologic examination of pleural    biopsy specimens, diffuse thickening of pleura on CT scanning, and bloody pleural    fluid, defined as &#8805; 100 000 red blood cells/mm<sup>3</sup> of pleural    fluid and exclusion of metastatic disease. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The sensitivity    of diagnostic tests was calculated as the proportion of diseased individuals    with positive test results, i.e. diseased with positive test divided by all    diseased. The gold standard for diagnosis of tuberculous PE and malignant PE    was demonstration of AFB from body fluids and tumour cells from tissue biopsy    samples respectively. </font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Results</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The mean age of    patients was 57 years (standard deviation 17 years) (range 12-82 years); 62%    were males and 72% were aged over 50 years. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Causes of exudative    PE</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">PE was right-sided    in 51% of cases, left-sided in 44% and bilateral in 5% of patients.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Malignant diseases    accounted for 41% and TB for 33% of the 100 cases of exudative PE; 2 patients    (2%) had coexistence of TB and malignancy and were analysed with the malignant    group. Para-pneumonia effusions were found in only 6% of cases. Other reasons    were: congestive heart failure, 3%; complication of coronary bypass surgery,    2%; rheumatoid arthritis, 2%; systemic lupus erythaematosus, 1%; chronic renal    failure, 1%; acute cholecystitis, 1%; unknown etiology, 8%. Large pleural effusions    were found in 24% of patients, moderate in 58%, and mild effusions in 18%. In    15% of cases, the pleural fluid was bloody.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The majority of    cases of malignant PE were due to metastatic cancers (95%). In this study the    origins of primary cancers were determined in only 39% of patients, which included    lung cancer (22%), breast cancer (7%), gastric carcinoma (5%) and lymphoma (5%).    Malignant mesothelioma was diagnosed in only 2 patients. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Characteristics    of tuberculous PE and malignant PE </b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The characteristics    and the presenting features of tuberculous PE and malignant PE are summarized    in <a href="#tab01">Table 1</a>. The most common presenting features of exudative    PE for tuberculous and malignant pleurisy respectively were: dyspnoea (82%,    72%), cough (82%, 65%) and pleuritic chest pain (64%, 49%).</font></p>     <p><a name="tab01"></a></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/emhj/v13n4/a03tab01.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The presenting    features of non-TB and non-malignant effusions were pleuritic chest pain, cough    and dyspnoea in 71%, 54% and 38% of patients respectively. In 8% of patients    the causes of exudative PE were not determined over a mean follow-up period    of 3 months. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Pleural biopsy    versus pleural fluid analysis</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Pleural biopsy    was the most sensitive diagnostic measure for tuberculous PE with a sensitivity    of 70%, whereas pleural fluid analysis was positive in only 33% of patients    with tuberculous PE (<a href="/img/revistas/emhj/v13n4/a03tab02.gif">Table 2</a>). The sensitivity    of pleural fluid analysis and pleural biopsy for diagnosis of malignant PE was    70% and 53.5% respectively, whereas the diagnostic sensitivity of both pleural    biopsy and pleural fluid analysis in patients with tuberculous and malignant    PE was 97% and 91% respectively. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The results of    alveolar lavage testing are presented in <a href="/img/revistas/emhj/v13n4/a03tab03.gif">Table    3</a>. Sputum smears and cultures were not helpful for diagnosis of tuberculous    PE and tuberculin skin test was positive in only 25% of patients with TB. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In patients with    malignant PE who had cytology-negative pleural fluid, pleural biopsy was positive    in 9 out of 13 patients (70%). In the remaining 4 cytology-negative cases 3    patients were diagnosed by bronchial biopsy and 1 patient by lymph node biopsy.    In 14 cases of malignant PE, both pleural biopsy and pleural fluid analysis    were positive. Patients with malignant PE were older, with higher frequency    of large and bloody pleural effusions as well as higher frequency of right-sided    effusions than patients with tuberculous PE. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In conclusion,    pleural fluid analysis was more sensitive for diagnosis of malignant PE than    tuberculous PE, whereas pleural biopsy was more sensitive for diagnosis of tuberculous    PE. Combined pleural fluid analysis and pleural biopsy were positive in 97%    and 91% of cases with tuberculous PE and malignant PE respectively. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Characteristics    of the malignant and non-malignant pleural fluids</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Characteristics    of the malignant and non-malignant pleural fluids are shown in Table 3. In malignant    PE the mean pleural fluid protein concentration was significantly higher but    the mean pleural fluid LDH level was significantly lower than in non-malignant    effusions (<i>P</i> &lt; 0.02 for both). </font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This study examined    the effectiveness of pleural fluid analysis and pleural biopsy in diagnosis    and differentiation of TB and malignancy in 100 hospitalized patients with exudative    PE. The results revealed that malignancy was the leading cause of exudative    PE in this group of patients in Babol (43%), while TB accounted for only 33%    of cases. Furthermore, these findings indicate that despite the development    of new diagnostic procedures, pleural fluid analysis and pleural biopsy, and    in particular combinations of both procedures, remain valuable diagnostic methods    for establishing the etiology and differentiating tuberculous PE from malignant    PE in patients with exudative PE. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The causes of exudative    PE vary according to geographic region as well as the study population. Several    factors including, age, smoking habits, exposure to environmental factors or    occupational risk factors may increase the risk of malignancies, whereas crowding,    poverty and malnutrition are associated with increased risk of TB. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Our study contrasts    with 2 epidemiological studies from TB-endemic areas, where TB was the most    common cause of exudative PE (43.7% and 44.1% of patients), whereas malignant    diseases accounted for 32.1% and 29.6 % of patients respectively &#91;<i>5,6</i>&#93;.    However, in 2 other studies from TB-endemic areas, malignant diseases were more    frequent than TB &#91;<i>9,10</i>&#93;. In another study of patients with exudative    or transudative pleural effusions in the Islamic Republic of Iran, malignant    diseases were more frequent than TB &#91;<i>8</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In this study we    have investigated a cohort of patients with exudative PE who underwent diagnostic    thoracentesis. The majority of these patients were referred from other health    centres for further investigation because of persistent PE. The population of    this study did not include all cases of PE because several cases of tuberculous    PE or malignant PE with obvious clinical and radiological findings who did not    require further diagnostic measures were not referred. Therefore, the present    study entailed only inpatients, mostly with longstanding and probably advanced    disease. The study population of the present study differs from the epidemiological-based    study population regarding patient selection. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The low prevalence    of parapneumonia effusions and congestive heart failure in this study was also    due to exclusion of patients with obvious clinical findings of pneumonia and    congestive heart failure who did not require diagnostic pleural fluid analysis    and pleural biopsy. However, in this study, the causes of exudative PE were    undetermined in 8% of patients after follow-up for a mean period of 3 months;    this value is lower than that reported by Zabokis et al. &#91;<i>9</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We obtained a yield    of 70% for pleural biopsy in diagnosis of tuberculous PE and 54% for malignant    PE. The diagnostic yield of pleural fluid analysis was 33% for tuberculous PE    and 70% for malignant PE. The yields of either pleural fluid analysis or pleural    biopsy or both for diagnosis of tuberculous PE and malignant PE were 97% and    91% respectively. The etiological diagnosis in 93% of the entire population    was established by performance of pleural fluid analysis and pleural biopsy.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The diagnostic    yields of pleural biopsy and pleural fluid analysis for diagnosis of tuberculous    PE and malignant PE vary according to published studies &#91;<i>9-12,14-18</i>&#93;.    Salazar-Lezama et al. found pleural biopsy to be the most effective method in    diagnosis of pathology in 87% of cases with tuberculous PE &#91;<i>16</i>&#93;, whereas    in another study of patients with tuberculous PE the diagnostic yield of pleural    biopsy was 47.4% which was lower than our study &#91;<i>17</i>&#93;. In a study by Christopher    et al. the diagnostic yield of pleural biopsy was 75% in tuberculous PE and    71% in patients with malignant PE &#91;<i>11</i>&#93;. Mohamed et al. obtained a diagnostic    yield of 60% in tuberculous PE and 50% in malignant PE, but the yields for thoracoscopic    biopsy were 93% and 94% respectively &#91;<i>10</i>&#93;. In a study by Jain et al.    the diagnostic yields of visceral pleural biopsy in tuberculous PE and malignant    PE were 69.7% and 81.3%, and parietal pleural biopsy were 42.3% and 31.3% respectively    &#91;<i>18</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The proportion    of patients with malignant PE who had positive pleural fluid analysis in these    studies ranged from 62% to 76% &#91;<i>9,10,12</i>&#93; and the positivity rate of pleural    fluid cultures in patients with tuberculous PE ranged from 7.9% to 73% &#91;<i>12,14-17,19</i>&#93;.    </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Chen et al. compared    the diagnostic value of echo-guided pleural biopsy with that of pleural fluid    analysis in patients with malignant PE &#91;<i>12</i>&#93;. They obtained a diagnostic    yield of 55% with pleural biopsy and 64% with pleural fluid analysis. Combining    both methods increased the diagnostic rate to 88% in patients with malignant    PE, which compares with 91% for our study. In another study of patients with    malignant PE, the diagnostic yields of lavage cytologic analysis and fluid cytologic    analysis were 84% and 62% respectively whereas the diagnostic yield of combined    thoracoscopy and lavage cytologic analysis was 96% &#91;<i>10</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In addition to    the present study, several previous studies have shown a higher sensitivity    of pleural fluid analysis than pleural biopsy in the diagnosis of malignant    PE and superiority of pleural biopsy in diagnosis of tuberculous PE &#91;<i>19-24</i>&#93;.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The diagnostic    yields of combined pleural fluid analysis and pleural biopsy in 3 previous studies    for diagnosing malignant PE ranged from 64.7% to 94% and for diagnosis of tuberculous    PE ranged 86% to 93% &#91;<i>20-22</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Furthermore in    this study, 9 out of 13 (70%) cytology-negative pleural fluid samples were diagnosed    as having malignant PE by pleural biopsy. In a study by Prakash et al. &#91;<i>20</i>&#93;    the diagnostic sensitivity of pleural biopsy in cytology-negative malignancy    was 7.1%. In the current study, the yields of pleural fluid analysis for diagnosis    of malignant PE and pleural biopsy for diagnosis of TB, in particular the sensitivity    of combined pleural fluid analysis and pleural biopsy, was higher. This may    be due to advanced cases of malignant disease with extensive involvement of    the parietal pleura. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In this study tuberculin    skin test, sputum smears and cultures were not helpful for diagnosis of TB.    However, the low positive rate of these tests was also reported in previous    studies &#91;<i>12,15,17,25</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">With regard to    the clinical data presented here, large, bloody and right-sided PE with a high    protein concentration favours the diagnosis of malignant PE rather than TB.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In summary, the    findings of the present study in confirmation with previous studies indicate    that TB and malignancy are the most probable causes of exudative PE. Additionally,    these results confirm that, despite the development of new diagnostic procedures,    pleural fluid analysis and pleural biopsy remain the best diagnostic methods    for evaluation of PE, as well as for determining the etiology in patients with    exudative PE. </font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Storey DD, Dines    DE, Coles DT. Pleural effusion: a diagnostic dilemma. <i>Journal of the American    Medical Association</i>, 1976, 236:2183-6. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000290&pid=S1020-3397200700040000400001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2.   Gannels JJ.    Perplexing pleural effusion. <i>Chest</i>, 1978, 47:390-3. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3.   Keshmiri M,    Hashemzadeh M. Use of cholesterol in differentiating of exudative and transudative    pleural effusions. <i>Medical journal of the Islamic Republic of Iran</i>, 1997,    2(3):187-9. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4.   Sahn SA. Pleural    anatomy, physiology and diagnostic procedures. In: Baum GL et al., eds. <i>Textbook    of pulmonary diseases</i>, 6th ed. Philadelphia, Lippincott-Raven, 1998:255-65.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5.   Kalaajieh    WK. Etiology of exudative pleural effusion in adults in north Lebanon. <i>Canadian    respiratory journal</i>, 2001, 8(2):93-7. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.   Liam CK, Lim    KH, Wong CM. Causes of pleural exudates in a region with a high incidence of    tuberculosis. <i>Respirology</i>, 2000, 5:33-8. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7.   Hsu CJ et    al. Tuberculous pleurisy with effusion. <i>Journal of the Formosan Medical Association</i>,    1999, 98 (10):678-82. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8.   Golshan M    et al. Common causes of pleural effusion in referral hospital in Isfahan, Iran    1997-1998. <i>Asian cardiovascular &amp; thoracic annals</i>, 2002, 10:43-6.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9.   Zablockis    R, Nargela R. Pleuros skyscio citologinio tyrimo diagnostine reiksme. &#91;Diagnostic    value of pleural fluid cytologic examination.&#93; <i>Medicina (Kaunas, Lithuania)</i>,    2002, 38:1171-8. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.  Mohammad KH    et al. Pleural lavage, a novel diagnostic approach for diagnosing exudative    pleural effusion. <i>Lung</i>, 2000, 178:371-9</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.  Christopher    DJ, Peter JV, Cherian AM. Blind pleural biopsy using a Tru-cut needle in moderate    to large pleural effusion-an experience. <i>Singapore medical journal</i>, 1998,    39:196-9. </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.  Chen NH, Hsieh    IC, Tsao TC. Comparison of the clinical diagnostic value between pleural needle    biopsy and analysis of pleural effusion. <i>Changgeng yi xue za zhi</i>, 1997,    20(1):11-6. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.  Broadus VC,    Light RW. Disorders of pleura. General principles and diagnostic approach. In:    Murray JF, Nadel JA, eds. <i>Textbook of respiratory medicine</i>, 2nd ed. Philadelphia,    WB Saunders, 1994:2145-63. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.  Valdes L et    al. Tuberculous pleurisy: a study of 254 patients. <i>Archives of internal medicine</i>,    1998, 158(18):2017-21. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.  Fijalkowski    M, Graczyk J. Gruzlicze zapalenie oplucnej-nadal trudny problem diagnostyczny.    &#91;Tuberculous pleurisy-still difficult diagnostic problem.&#93; <i>Polski merkuriusz    lekarski</i>, 2001, 11:389-93. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.  Salazar-Lezama    M et al. Diagnostic methods of primary tuberculous pleural effusion in region    with high prevalence of tuberculosis. A study in Mexican population. <i>Revista    de investigacion clinica</i>, 1997, 49:453-6. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.  Kazuhiro K    et al. &#91;A clinical study of tuberculous pleurisy.&#93; <i>Kansenshogaku zasshi</i>,    2002, 76:18-22 &#91;in Japanese&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.  Jain NK et    al. Visceral and parietal biopsy in etiological diagnosis of pleural diseases.    <i>Journal of the Association of Physicians of India</i>, 2000, 48:776-80. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19.  Inoue Y et    al. &#91;The usefulness of pleural biopsy in benign or malignant pleurisy.&#93; <i>Nihon    Kyobu Shikkan Gakkai zasshi</i>, 1991, 29:332-7 &#91;in Japanese&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20.  Prakash UB,    Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation    of pleural effusion: analysis of 414 cases. <i>Mayo Clinic proceedings</i>,    1985, 60:158-64. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21.  Frist B, Kahan    AV, Koss LG. Comparison of the diagnostic values of biopsies of the pleura and    cytologic evaluation of pleural fluids. <i>American journal of clinical pathology</i>,    1979, 72:48-51.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22.  Escudero BC    et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens    with Cope’s needle. Study of 414 patients. <i>Archives of internal medicine</i>,    1990, 150:1190-4. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23.  Salyer WR,    Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid    cytopathology in the diagnosis of malignant neoplasm involving the pleura. <i>Chest</i>,    1975, 67:536-9. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24.  Ong KC et    al. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.    <i>Singapore medical journal</i>, 2000, 41:19-23. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25.  Kawanjana    IH et al. Sputum-smear examination in patients with extrapulmonary tuberculosis    in Malawi. <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>,    2000, 94:359-8. </font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Received: 26/07/05;    accepted: 05/10/05</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>             <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>World Health    Assembly resolution on TB</b> </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">On 23 May 2007,    the 60th World Health Assembly passed a resolution urging WHO Member States    to develop and implement long-term plans for TB prevention and control aimed    at accelerating progress towards halving TB deaths and prevalence by 2015, through    the full implementation of the Global Plan to Stop TB, 2006-2015. WHO is requested    to strengthen its support to countries affected by TB, in particular those heavily    affected by Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB    (XDR-TB), as well as TB/HIV. Member States are also urged, where warranted,    to declare TB an emergency. The Global Plan to Stop TB 2006-2015 is a comprehensive    assessment of the action and resources needed to implement the Stop TB strategy    and make an impact on the global TB burden. The plan can be downloaded in Arabic,    English, French and Spanish from the homepage. Actions for Life, a flash film    about the Global Plan can be accessed on the same page, URL <a href="http://www.stoptb.org/globalplan/" target="_blank">http://www.stoptb.org/globalplan/</a></font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Storey]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Dines]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Coles]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pleural effusion: a diagnostic dilemma]]></article-title>
<source><![CDATA[Journal of the American Medical Association]]></source>
<year>1976</year>
<volume>236</volume>
<page-range>2183-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
